Verified ProfileEN

Haotai Health Jisheng (Jilin) Biotechnology Co., Ltd.

Order verification — $199

Manufacturing · Slaughtering and Meat Processing

Verification dossier

Haotai Health Jisheng (Jilin) Biotechnology Co., Ltd. is a Chinese company based in Tonghua, Jilin. The company operates in the slaughtering and meat processing sector, within the broader manufacturing industry. Established 2022, the company has been operating for 4 years.

Sinolinks tracks Haotai Health Jisheng (Jilin) Biotechnology Co., Ltd. as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

Licensed items: drug production; food production; feed production; health product (non-food) production; cosmetic production; drug retail; entrusted drug production; alcohol business; alcoholic beverage production; road cargo transport (excluding dangerous goods); animal casing processing; heat production and supply; second-class medical device production; third-class medical device production; third-class medical device operation; pet feed (pet food) production. General items: food sales (pre-packaged food only); health product (non-food) sales; bio-based material manufacturing; retail of edible agricultural products; bio-based material sales; bio-feed research and development; feed…

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review